Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

5

Revenue 2017

Merck & Co.

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck & Co.'s 2013 sales performance.

Merck

Lynparza cleared for first-line ovarian cancer use in China

Lynparza cleared for first-line ovarian cancer use in China

Continues to cement lead in PARP inhibitor category. AstraZeneca and its marketing partner MSD (known as Merck &Co in North America) have scored marketing authorisation in China for their PARP inhibitor ... Although Lynparza has been the lead in the PARP

UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial

UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial According to UCB, bimekizumab met its co-primary endpoints at week 16 of the study, demonstrating superiority over Humira in achieving a 90% improvement in the psoriasis area, severity index and

Envision Pharma Group announces changes in its executive team

Envision Pharma Group announces changes in its executive team Brian Hepburn (left), Envision Pharma Group executive co-chair, and David Thompson, chief executive officer (right). ... The move coincides with the appointment of current CEO Brian Hepburn to the new position of executive co-chair of the group.

Mylan, Biocon’s Herceptin biosimilar launched in US

Mylan, Biocon’s Herceptin biosimilar launched in US MSD – known as Merck &Co in North America – was the  first to launch a biosimilar of Herceptin in the EU, under the Ontruzant brand name.

AstraZeneca eyes early 2020 FDA verdict on Imfinzi in SCLC

AstraZeneca eyes early 2020 FDA verdict on Imfinzi in SCLC Merck &Co/MSD’s PD-1 inhibitor Keytruda (pembrolizumab) – already dominating NSCLC therapy – is already approved for third-line SCLC treatment and is in a first-line phase 3 trial

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics